Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Typical traders, spread fear.
Focus on the 10m materials order from the government. Sadly there will be some poor Pi who will lose out when Omega are producing And selling 2.5m tests per week.
What will the SP be then. £2+ easily.
Good points, there does seem to be a plan to undermine the sp first thing a sign I have seen many times to enable MMs to accumulate shares prior to a rise. AIM is inherently dishonest and easily manipulated.
We are not reliant on RTC tests at all. We have one of the best hedges product portfolios.
The best antibody lateral flow test
The only approved triple antibody lateral flow test
Competitive Elisa lab test
Elisa antigen test
Lateral flow antigen test
Per CK business plan 80% of the capacity is reserved for non UK RTC tests, so how can we be too reliant on them. You have no idea what the situation is with sales of other products until the trading update and presentation next week.
People are massively missing the value here.
It’s only accepted from two countries. Costs £80
"Lamp test is not recognised by many countries, as not accurate . This is just a showcase, a bit of theater."
DHSC are rolling out LAMP testing to hospital trials - despite it being basically an unproven technology, with questions over accuracy. It's a symptom of Hattie Manc0ck's fascination with all things that go 'beep'...
Ive doubled my initial investment in a short few months...if that is a clue as to whats coming then i will continue to buy. You dont ramp up production capacity by that much without a reason, and the patient investor will win big.
To those that cant wait, thanks. I will have your shares. Keep em coming...
Lamp test is not recognised by many countries, as not accurate . This is just a showcase, a bit of theater.
Lateral flow test from Malogic is the only solution.
"MB issue is odx is becoming too reliant on rtc kits. They've had no sales for India, Africa or any other supply chain."
I don't think it is ODX becoming too reliant on RTC kits... I think the issue is impatient PIs thinking that Covid19 is the be all and end all of ODX, and basing their actions purely on gossip, Twitter and the odd RNS.
ODX is about much more than Covid19 and the UK-RTC. It's not really a stock for speculative day trading but for long term holding.
MB issue is odx is becoming too reliant on rtc kits. They've had no sales for India, Africa or any other supply chain.
Nobody is asking odx to take over the world, (I think you might be mixed up with another stock) just to sell enough tests to use its capacity, and with the products they have and their capacity being a tiny portion of the amount of tests globally needed, it won’t be a problem.
Because they are sad gits who are trying to get a lower entry price or just like to read their pearls of wisdom on these boards
P off you a*sewipe
Why do some people want people to to fail on shares and loose monies
I just don’t understand people hence why I don’t really mix with people
This share will do well plus other Covid shares will
UP THE VILLA HARDCORE
Coming from a guy who has shares in TUI/IAG etc I think your advice will be taken with a pinch of salt
And you’re posting why??????
Agreed:some companies will miss out;hopefully not ODX
Pumpky this whole rise this year has been Covid related
The minute ODX is red carded a blood bath will occur. I sold out at 1.03 and have ZERO intention of buying back in
It was crazy that some AIM stock was going to take over the market
In my experience LAMP works very well if there's an abundance of target DNA. Id be suspicious that low positives will be below the limit of detection of that assay.
There will be buyers for mologic lft no matter
The lamp test is being used as it doesn’t require a lab and can be done it 20 mins but they admit it’s not as good. The antigen reference is the need to send to labs and there is no validated antigen poc so they can’t reference that as yet
In regards being left behind, they are now selling all forms of validated antibody test bar direct to public which they await and bearing in mind first vaccine by spring at earliest and the need to use with vaccines I’m not so sure their late
In regards antigen would have been good to have from feb but it doesn’t unfortunately work like that, again how long will this be here for and honestly is there a better, quicker more cost effective test than a validated point of care? The question will be is the waiting worth while.
Will the best tests gets their moment?
Think it said preferred
Scharn , where does it say that
Think 25 is a bit of a stretch! Can see this @80p without new news;no major institutions on board;
Always but ALWAYS jam tomorrow with this company
Its getting left behind. If it doesnt break into the market very very smartly this will be back to 25p in a heartbeat
Evening express/ evening standard,etc. article states Lamp will be rolled out initially. Antigen test to follow in the coming weeks. Sorry. Can't copy and paste.
The article states the lamp test by Collinson is better than the antigen tests (Mologic).